Alpelisib

Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T1921-5mg 5 mg

7 - 10 business days*

48.00€
TGM-T1921-1mL 1 ml

7 - 10 business days*

52.00€
TGM-T1921-10mg 10 mg

7 - 10 business days*

62.00€
TGM-T1921-25mg 25 mg

7 - 10 business days*

75.00€
TGM-T1921-50mg 50 mg

7 - 10 business days*

91.00€
TGM-T1921-100mg 100 mg

7 - 10 business days*

147.00€
TGM-T1921-500mg 500 mg

7 - 10 business days*

444.00€
 
Description: Alpelisib (BYL-719) is a PI3Kalpha inhibitor (IC50=5 nM) with selective, potent, and... more
Product information "Alpelisib"
Description: Alpelisib (BYL-719) is a PI3Kalpha inhibitor (IC50=5 nM) with selective, potent, and oral activity, inhibiting PI3Kbeta/gamma/delta with low activity (IC50=250/290/1200 nM). Alpelisib demonstrates antitumor activity and specifically targets PIK3CA mutant tumors. Target: PI3K. Smiles: Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F. References: Gobin B, et al. BYL719, a new alpha-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma. Int J Cancer. 2015 Feb 15,136(4):784-96.
Keywords: BYL-719
Supplier: TargetMol
Supplier-Nr: T1921

Properties

Application: Targets phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta
MW: 441.47 D
Formula: C19H22F3N5O2S

Database Information

CAS : 1217486-61-7| Matching products
KEGG ID : K00922 | Matching products
Protein Atlas Nr. : Lipid / Phosphoinositial Signaling

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H373
P Phrases: P260, P314, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Alpelisib"
Write a review
or to review a product.
Viewed